Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study

References

• Andrade FB, Gualberto A, Rezende C, Percegoni N, Gameiro J, Hottz ED. The weight of obesity in immunity from influenza to COVID-19. Front Cell Infect Microbiol. 2021;11:638852. doi:10.3389/fcimb.2021.638852
   PubMed Web of Science ®Google Scholar
• Aly MH, Rahman SS, Ahmed WA, et al. Indicators of critical illness and predictors of mortality in COVID-19 Patients. Infect Drug Resist. 2020;13:1995–2000. doi:10.2147/IDR.S261159
   PubMed Web of Science ®Google Scholar
• Ghweil AA, Hassan MH, Khodeary A, et al. Characteristics, outcomes and indicators of severity for COVID-19 among sample of ESNA quarantine hospital’s patients, Egypt: a retrospective study. Infect Drug Resist. 2020;13:2375–2383. doi:10.2147/IDR.S263489
   PubMed Web of Science ®Google Scholar
• Mohammed AEAH, Mahmoud SAAA, N HAAE, Mohammed HM, Abd-EL Razek GM, Rabea DBM. Outcome of acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients. SVU Int J Med Sci. 2023;6(2):531–540. doi:10.21608/svuijm.2023.202111.1557
   Google Scholar
• Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9(6):350–359. doi:10.1016/S2213-8587(21)00089-9
   PubMed Web of Science ®Google Scholar
• Ye P, Pang R, Li L, Li HR, Liu SL, Zhao L. Both underweight and obesity are associated with an increased risk of coronavirus disease 2019 (COVID-19) Severity. Front Nutr. 2021;8:649422. doi:10.3389/fnut.2021.649422
   PubMed Web of Science ®Google Scholar
• Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. doi:10.1056/NEJMoa1614362
   PubMed Web of Science ®Google Scholar
• Soeroto AY, Soetedjo NN, Purwiga A, et al. Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(6):1897–1904. doi:10.1016/j.dsx.2020.09.029
   PubMed Web of Science ®Google Scholar
• Földi M, Farkas N, Kiss S, et al. Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis. Obes Rev. 2020;21(10):e13095. doi:10.1111/obr.13095
   PubMed Web of Science ®Google Scholar
• Jose RJ, Manuel A. Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome? Obesity. 2020;28(6):1007. doi:10.1002/oby.22835
   PubMed Web of Science ®Google Scholar
• Galal I, Hussein AARM, Mohammed MM, et al. Is there a correlation between pulmonary inflammation index with COVID-19 disease severity and outcome? SVU Int J Med Sci. 2022;5(2):35–50. doi:10.21608/svuijm.2022.119822.1271
   Google Scholar
• World Health Organization. Egypt: WHO statistical profile; 2012. Available from: https://www.who.int/gho/countries/egy.pdf. Accessed August 28, 2023.
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19); 2020. Available from: https://www.who.int/publications-detail/report-of-The-who-china-joint-mission-on-coronavirus-disease-2019-covid-19. Accessed August 28, 2023.
   Google Scholar
• Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415–421. doi:10.1016/s0261-5614(03)00098-0
   PubMed Web of Science ®Google Scholar
• Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295(3):715–721. doi:10.1148/radiol.2020200370
   PubMed Web of Science ®Google Scholar
• Mehanna O, El Askary A, Ali E, El Esawy B, FathAlla T, Gharib AF. Impact of obesity and its associated comorbid conditions on COVID-19 presentation. Diabetes Metab Syndr Obes. 2021;14:409–415. doi:10.2147/DMSO.S287779
   PubMed Web of Science ®Google Scholar
• Schaalan M, Abou Warda AE, Osman SM, et al. The impact of sociodemographic, nutritional, and health factors on the incidence and complications of COVID-19 in Egypt: a cross-sectional study. Viruses. 2022;14(3):448. doi:10.3390/v14030448
   PubMed Web of Science ®Google Scholar
• Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis. 2020;71(15):706–712. doi:10.1093/cid/ciaa199
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Almazeedi S, Al-Youha S, Jamal MH, et al. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. E Clinical Medicine. 2020;24:100448. doi:10.1016/j.eclinm.2020.100448
   Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020
   PubMed Web of Science ®Google Scholar
• Khamiss AM, El-Dahshan M, El-Ghamery F, Aggag M, Hashim A, Eliwa A. Outcomes of COVID-19 in Egyptian patients. Al-Azhar Medical J. 2021;50(1):765–782. doi:10.21608/amj.2021.139876
   Google Scholar
• Hendren NS, de Lemos JA, Ayers C, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American heart association COVID-19 cardiovascular disease registry. Circulation. 2021;143(2):135–144. doi:10.1161/CIRCULATIONAHA.120.051936
   PubMed Web of Science ®Google Scholar
• Cai H, Yang L, Lu Y, et al. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study. BMC Infect Dis. 2021;21(1):147. doi:10.1186/s12879-021-05818-0
   PubMed Web of Science ®Google Scholar
• Espiritu AI, Reyes NGD, Leochico CFD, et al. Body mass index and its association with COVID-19 clinical outcomes: findings from the Philippine Corona study. Clin Nutr ESPEN. 2022;49:402–410. doi:10.1016/j.clnesp.2022.03.013
   PubMed Web of Science ®Google Scholar
• Larrazabal RB, Perez BMB, Masamayor EMI, Chiu HHC, Palileo-Villanueva LAM. The prevalence of malnutrition and analysis of related factors among adult patients with the Coronavirus Disease 2019 (COVID 19) in a tertiary government hospital: the MalnutriCoV study. Clin Nutr ESPEN. 2021;42:98–104. doi:10.1016/j.clnesp.2021.02.009
   PubMed Web of Science ®Google Scholar
• Blokhin IA, Gonchar AP, Kodenko MR, Solovev AV, Gombolevskiy VA, Reshetnikov RV. Impact of body mass index on the reliability of the CT0–4 grading system: a comparison of computed tomography protocols. Digital Diagnostics. 2022;3(2):108–118. doi:10.17816/DD104358
   Google Scholar
• Lu X, Cui Z, Ma X, et al. The association of obesity with the progression and outcome of COVID-19: the insight from an artificial-intelligence-based imaging quantitative analysis on computed tomography. Diabetes Metab Res Rev. 2022;38(4):e3519. doi:10.1002/dmrr.3519
   PubMed Web of Science ®Google Scholar
• Luo X, Jiaerken Y, Shen Z, et al. Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging. Diabetes Obes Metab. 2021;23(1):290–293. doi:10.1111/dom.14194
   PubMed Web of Science ®Google Scholar
• Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4
   PubMed Web of Science ®Google Scholar
• Haraj NE, El Aziz S, Chadli A, et al. Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit. Clin Nutr ESPEN. 2021;41:423–428. doi:10.1016/j.clnesp.2020.09.214
   PubMed Web of Science ®Google Scholar
• Kim TS, Roslin M, Wang JJ, et al. BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York. Obesity. 2021;29(2):279–284. doi:10.1002/oby.23076
   PubMed Web of Science ®Google Scholar
• Li T, Zhang Y, Gong C, et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr. 2020;74(6):871–875. doi:10.1038/s41430-020-0642-3
   PubMed Web of Science ®Google Scholar
• Berger MM. Nutrition Status Affects COVID-19 Patient Outcomes. JPEN J Parenter Enteral Nutr. 2020;44(7):1166–1167. doi:10.1002/jpen.1954
   PubMed Web of Science ®Google Scholar
• Huh K, Lee R, Ji W, et al. Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: a matter of sexual dimorphism? Diabetes Res Clin Pract. 2020;170:108515. doi:10.1016/j.diabres.2020.108515
   PubMed Web of Science ®Google Scholar
• Li Y, Tong S, Hu X, et al. The relationship between nutritional status and the prognosis of COVID-19: a retrospective analysis of 63 patients. Medicine. 2021;100(14):e25287. doi:10.1097/MD.0000000000025287
   PubMed Web of Science ®Google Scholar
• Al-Salameh A, Lanoix JP, Bennis Y, et al. The association between body mass index class and coronavirus disease 2019 outcomes. Int J Obes. 2021;45(3):700–705. doi:10.1038/s41366-020-00721-1
   Web of Science ®Google Scholar
• Czernichow S, Beeker N, Rives-Lange C, et al. Obesity doubles mortality in patients hospitalized for severe acute respiratory syndrome coronavirus 2 in Paris hospitals, France: a Cohort Study on 5795 Patients. Obesity. 2020;28(12):2282–2289. doi:10.1002/oby.23014
   PubMed Web of Science ®Google Scholar
• Sawadogo W, Tsegaye M, Gizaw A, Adera T. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis. BMJ Nutr Prev Health. 2022;5(1):10–18. doi:10.1136/bmjnph-2021-000375
   PubMedGoogle Scholar
• Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500–1515. doi:10.1007/s00125-020-05180-x
   PubMed Web of Science ®Google Scholar
• Busetto L, Bettini S, Fabris R, et al. Obesity and COVID-19: an Italian Snapshot. Obesity. 2020;28(9):1600–1605. doi:10.1002/oby.22918
   PubMed Web of Science ®Google Scholar
• Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195–1199. doi:10.1002/oby.22831
   PubMed Web of Science ®Google Scholar
• Rao X, Wu C, Wang S, et al. The importance of overweight in COVID-19: a retrospective analysis in a single center of Wuhan, China. Medicine. 2020;99(43):e22766. doi:10.1097/MD.0000000000022766
   PubMed Web of Science ®Google Scholar
• Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi:10.1016/j.metabol.2020.154262
   PubMed Web of Science ®Google Scholar
• Kooistra EJ, de Nooijer AH, Claassen WJ, et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes. 2021;45(3):687–694. doi:10.1038/s41366-021-00747-z
   Web of Science ®Google Scholar
• Caussy C, Pattou F, Wallet F, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8(7):562–564. doi:10.1016/S2213-8587(20)30160-1
   PubMed Web of Science ®Google Scholar
• Gao F, Zheng KI, Wang XB, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020;43(7):e72–e74. doi:10.2337/dc20-0682
   PubMed Web of Science ®Google Scholar
• Ritter A, Kreis NN, Louwen F, Yuan J. Obesity and COVID-19: molecular mechanisms linking both pandemics. Int J Mol Sci. 2020;21(16):5793. doi:10.3390/ijms21165793
   PubMed Web of Science ®Google Scholar
• Severin R, Arena R, Lavie CJ, Bond S, Phillips SA. Respiratory muscle performance screening for infectious disease management following COVID-19: a highly pressurized situation. Am J Med. 2020;133(9):1025–1032. doi:10.1016/j.amjmed.2020.04.003
   PubMed Web of Science ®Google Scholar
• Abdelmotaleb MS. Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients. SVU Int J Med Sci. 2022;5(2):253–261. doi:10.21608/svuijm.2022.136679.1310
   Google Scholar
• Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071. doi:10.3389/fimmu.2019.01071
   PubMed Web of Science ®Google Scholar
• Hussain A, Mahawar K, Xia Z, Yang W, El-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract. 2020;14(4):295–300. doi:10.1016/j.orcp.2020.07.002
   PubMed Web of Science ®Google Scholar
• Heubel AD, Viana AA, Linares SN, et al. Determinants of endothelial dysfunction in noncritically ill hospitalized COVID-19 patients: a cross-sectional study. Obesity. 2022;30(1):165–171. doi:10.1002/oby.23311
   PubMed Web of Science ®Google Scholar
• Wang SY, Singh A, Eder MD, et al. Association of obesity with venous thromboembolism and myocardial injury in COVID-19. Obes Res Clin Pract. 2021;15(5):512–514. doi:10.1016/j.orcp.2021.07.003
   PubMed Web of Science ®Google Scholar
• Elmalky I, Dongol E, Abdelkhalek H. Neurological Diseases: cause and Effect in the Era of COVID-19. SVU Int J Med Sci. 2021;4(2):25–37. doi:10.21608/svuijm.2021.63964.1094
   Google Scholar
• Yanover C, Mizrahi B, Kalkstein N, et al. What factors increase the risk of complications in SARS-CoV-2-Infected Patients? A cohort study in a nationwide Israeli health organization. JMIR Public Health Surveill. 2020;6(3):e20872. doi:10.2196/20872
   PubMedGoogle Scholar
• Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: consensus report of the acute disease quality initiative (ADQI) 21 workgroup. Intensive Care Med. 2020;46(4):654–672. doi:10.1007/s00134-019-05869-7
   PubMed Web of Science ®Google Scholar
• Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16(7):341–342. doi:10.1038/s41574-020-0364-6
   PubMed Web of Science ®Google Scholar
• Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020;142(1):4–6. doi:10.1161/CIRCULATIONAHA.120.047659
   PubMed Web of Science ®Google Scholar
• Kimura T, Namkoong H. Susceptibility of the obese population to COVID-19. Int J Infect Dis. 2020;101:380–381. doi:10.1016/j.ijid.2020.10.015
   PubMed Web of Science ®Google Scholar
• Augusto FD, de Souza AD, Pinho CP. Avaliação do risco e estado nutricional em pacientes com Covid-19 hospitalizados. Demetra. 2022;17:65441. doi:10.12957/demetra.2022.65441
   Google Scholar
• Ghizlane EA, Manal M, Abderrahim EK, et al. Lymphopenia in Covid-19: a single center retrospective study of 589 cases. Ann Med Surg. 2021;69:102816. doi:10.1016/j.amsu.2021.102816
   PubMed Web of Science ®Google Scholar
• Cai Q, Chen F, Wang T, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392–1398. doi:10.2337/dc20-0576
   PubMed Web of Science ®Google Scholar
• Elkarow MH, Hamdy A. A suggested role of human growth hormone in control of the COVID-19 pandemic. Front Endocrinol. 2020;11:569633. doi:10.3389/fendo.2020.569633
   PubMed Web of Science ®Google Scholar
• Ahmed GM. Managing diabetic patients during the coronavirus disease (COVID-19) pandemic. SVU Int J Med Sci. 2021;4(2):166–171. doi:10.21608/svuijm.2020.51252.1049
   Google Scholar
• Montefusco L, Ben Nasr M, D’Addio F, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774–785. doi:10.1038/s42255-021-00407-6
   PubMedGoogle Scholar
• Hyun S, Li X, Vermillion B, et al. Body mass index and pressure ulcers: improved predictability of pressure ulcers in intensive care patients. Am J Crit Care. 2014;23(6):494–500. doi:10.4037/ajcc2014535
   PubMed Web of Science ®Google Scholar
• Girard R, Baboi L, Ayzac L, Richard JC, Guérin C; Proseva trial group. The impact of patient positioning on pressure ulcers in patients with severe ARDS: results from a multicentre randomised controlled trial on prone positioning. Intensive Care Med. 2014;40(3):397–403. doi:10.1007/s00134-013-3188-1
   PubMed Web of Science ®Google Scholar
• Lima Serrano M, González Méndez MI, Carrasco Cebollero FM, Lima Rodríguez JS. Risk factors for pressure ulcer development in Intensive Care Units: a systematic review. Med Intensiva. 2017;41(6):339–346. English, Spanish. doi:10.1016/j.medin.2016.09.003
   PubMed Web of Science ®Google Scholar
• Challoner T, Vesel T, Dosanjh A, Kok K. The risk of pressure ulcers in a proned COVID population. Surgeon. 2022;20(4):e144–e148. doi:10.1016/j.surge.2021.07.001
   PubMed Web of Science ®Google Scholar